Stephanie Dulucq

18PUBLICATIONS
100CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMolecular targetsHaematologyMolecular evolution
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 15, 2026
Development and External Validation of a Transcriptome-Based Multivariable Prediction Model for Treatment-Free Remission in Chronic Myeloid Leukemia.

|May 15, 2025
Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from FRENVEX.

Vincent Jachiet, Olivier Kosmider, Maxime Beydon

|Dec 10, 2024
Mutation of Epigenetic Regulators at Diagnosis Is an Independent Predictor of Tyrosine Kinase Inhibitor Treatment Failure in Chronic Myeloid Leukemia: A Report From the RESIDIAG Study.

Hippolyte Guerineau, Jean-Michel Cayuela, Stéphanie Dulucq

|Aug 30, 2024
Characterization and Clinical Significance of Hemolysis After Pulsed Field Ablation for Atrial Fibrillation: Results of a Multicenter Analysis.

Miruna A Popa, Sandrine Venier, Roberto Menè

|Aug 19, 2024
Beta-thalassaemia intermedia due to a complex alpha-globin rearrangement and a heterozygous beta thalassaemia mutation.

Victor Marin, Yoann Huguenin, Lucile Bessi

|May 21, 2024
BCR::ABL1 digital PCR for treatment-free remission prediction in chronic myeloid leukemia patients: An individual participant data meta-analysis.

Camille Kockerols, Peter J M Valk, Stéphanie Dulucq

Pageof 3

Frequent Collaborators

6 joint publications

Gabriel Etienne

4 joint publications

Delphine Rea

2 joint publications

Franck E Nicolini

2 joint publications

Joëlle Guilhot